Common gene disorder doubles risk of lung cancer, even for nonsmokers
Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.
Researchers found that the genetic disorder, alpha-1 antitrypsin deficiency (Ą1ATD), could explain up to about 12 percent of lung cancer patients in this study and likely represents the same widespread risk in the general population. “This is a seriously underdiagnosed disorder and suggests that people who have lung cancer and chronic obstructive pulmonary diseases (COPD) in their families should be screened for these gene carriers,” says Ping Yang, M.D., Ph.D., a Mayo Clinic epidemiologist and lead investigator on the study.
Read the rest of this story - Click Here
Visit the new Summer Pages at COPD and So Much More
Related posts:
- Personalized, Gene-Based Risk Testing For Lung Cancer Gives New Tool To Help Smokers Quit Smokers who learn their personal risk of lung cancer...
- Five Gene Variants May Be Linked to Lung Disease Findings might lead to better treatments for asthma, COPD,...
- Experimental Drug Makes Lung Cancer Tumor Shrink In 90% Of Patients Medical News Today An extremely promising experimental drug, called...
- Coming Soon: Lung-Cancer Spray? Scientists may someday be able to fight lung cancer...
- Dietary boron reduces lung cancer risk in women Reuters Health reported on May 28 that higher amounts...
Related posts brought to you by Yet Another Related Posts Plugin.
May 28, 2008
Tags: alpha-1 antitrypsin deficiency, genetic COPD, genetic lung cancer Posted in: COPD - New Research and Findings
Leave a Reply